Pham Quang X (CIK 1405290) reported 29 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Sell CVKD (7,400 shares), Sell CVKD (2,127 shares), Sell CVKD (9,029 shares), Sell CVKD (9,167 shares), Sell CVKD (2,277 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman and CEO | Sell | 7,400 | $22,422 |
| 2026-06-26 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 2,127 | $6,381 |
| 2026-06-26 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 9,029 | $27,538 |
| 2026-06-24 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 9,167 | $32,543 |
| 2026-06-24 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 2,277 | $7,286 |
| 2026-06-18 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 3,613 | $11,489 |
| 2026-06-18 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 513 | $1,621 |
| 2026-06-10 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 5,893 | $25,811 |
| 2026-06-10 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 12,992 | $52,748 |
| 2026-06-10 | Cadrenal Therapeutics, Inc. (CVKD) | Chairman, CEO and Interim CFO | Sell | 3,500 | $14,735 |
| 2026-06-05 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 2,064 | $9,123 |
| 2026-06-05 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 3,898 | $17,190 |
| 2026-06-05 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 2,323 | $9,896 |
| 2026-06-02 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 303 | $1,518 |
| 2026-06-02 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 349 | $1,557 |
| 2026-05-29 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 6,476 | $37,302 |
| 2026-05-29 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 3,298 | $17,413 |
| 2026-05-29 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 2,989 | $14,736 |
| 2025-10-28 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 1,129 | $15,840 |
| 2025-10-28 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 1,315 | $18,397 |
| 2025-10-14 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 1,800 | $25,236 |
| 2025-10-14 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 1,800 | $25,470 |
| 2025-10-03 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 500 | $7,065 |
| 2025-10-01 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 419 | $5,870 |
| 2025-10-01 | Cadrenal Therapeutics, Inc. (CVKD) | CEO and Chairman | Sell | 881 | $12,343 |
Source: SEC Form 4 filings · as of 2026-07-01